ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company […]
AvidXchange Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) — AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leading provider of accounts payable (AP) […]
Leslie’s Appoints Benjamin Lindquist Senior Vice President, General Counsel & Corporate Secretary
PHOENIX, April 09, 2024 (GLOBE NEWSWIRE) — Leslie’s, Inc. (“Leslie’s”, “we”, “our”, “its”, or “Company”; NASDAQ: LESL), the largest and […]
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
For the first time, the company shares data for its preclinical IL-18 and IL-12 programs—candidate nominations for each are expected […]
Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]
Australian Oilseeds, Largest APAC Producer of Non-Chemical, Non- GMO “Cold-Processing” Vegetable Oil, Expands Australian Operations to the United States
~ Over the past 20 years, AOI has grown to be the largest cold pressing oil plant in theAPAC region, […]
Omega Flex, Inc. Announces Election of a Director: Stephen M. Shea
EXTON, Pa., April 09, 2024 (GLOBE NEWSWIRE) — Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announces that that our […]
Beamr to enable real-time video streaming over 5G with NVIDIA Holoscan for Media
Herzliya Israel, April 09, 2024 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and […]
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic […]
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
– Preclinical data presented at AACR demonstrate that combining IMM-1-104 with chemotherapies used in the treatment of first-line pancreatic cancer […]
